Pertussis Vaccine Market Segments 2024-2033: Size, Share, and Insights

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Pertussis Vaccine Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $6.33 billion In 2028 At A CAGR Of 3.6% :

The pertussis vaccine market size has grown steadily in recent years. It will grow from $5.26 billion in 2023 to $5.5 billion in 2024 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to disease prevalence, immunization programs, pediatric vaccination, regulatory approvals.

The pertussis vaccine market size is expected to see steady growth in the next few years. It will grow to $6.33 billion in 2028 at a compound annual growth rate (CAGR) of 3.6%. The growth in the forecast period can be attributed to booster vaccination, maternal immunization, immunization for healthcare workers, global health initiatives. Major trends in the forecast period include personalized immunization schedules, combination vaccines, vaccine equity initiatives, digital health for immunization.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=13023&type=smp

Pertussis Vaccine Market Major Segments
The pertussis vaccine market covered in this report is segmented -

1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine; Tdap (Tetanus, Diphtheria and Pertussis) Vaccine
2) By Vaccine Type: Whole-Cell Vaccine; Acellular Vaccine
3) By Application: Children; Adults; Infants
4) By End-User: Vaccination Centers; Hospitals; Clinics

Key Driver - Surge In Childbirth Rates Fuels Growth Of Pertussis Vaccine Market

Rising childbirth rates are driving the growth of the pertussis vaccine market going forward. Childbirth is the term for the act of giving birth to a child. It is the culmination of pregnancy, during which the fetus develops in the mother's uterus and marks the beginning of a new life outside the womb. The pertussis vaccine is primarily used for children because it helps protect them from whooping cough and other severe and potentially deadly diseases. For instance, in May 2022, according to the Center for Disease Control and Prevention (CDC), a US-based government organization, there were 3.66 million births in the US in 2021, compared to 3.61 million in 2020. Furthermore, in 2021, according to Statistics Canada, a Canada-based government agency, in Canada, births increased by 2% from 360,552 in 2020 to 367,684 in 2021. Therefore, the rising childbirth rates are driving the growth of the pertussis vaccine market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=13023&type=smp

Prominent Trend - Innovative Approvals Bolster Major Companies In The Pertussis Vaccine Market

Major companies operating in the pertussis vaccine market are developing innovative drugs and getting approvals to sustain their position in the market. For instance, in October 2022, GSK plc., a UK-based pharmaceutical and biotechnology company, announced that BOOSTRIX was approved by the U.S. Food and Drug Administration (FDA). BOOSTRIX is a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed (Tdap) vaccine. It is used during pregnancy to prevent pertussis (whooping cough) in newborn infants. It is injected once into the upper arm muscle. Boostrix is safe and effective for pregnant women and their babies. Additionally, it effectively prevents pertussis, including severe cases of the disease.

Pertussis Vaccine Market Players
Major players in the pertussis vaccine market are Pfizer Inc., Johnson And Johnson Pvt Ltd., Merck And Co. Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, BioNTech SE, Moderna Inc., Sinovac Biotech Ltd., CSL Limited, Astellas Pharma US Inc., Sanofi Pasteur SA, Mitsubishi Tanabe Pharma America Inc., PT Kalbe Farma Tbk, CSL Seqirus, Walvax Biotechnology Co.Ltd., Biological E. Limited, Serum Institute of India, Bavarian Nordic AS, PT Bio Farma, Bharat Biotech International Limited, Takeda Pharmaceutical Company, Panacea Biotec Limited, Beijing Minhai Biotechnology Co. Ltd., Protein Sciences Corporation, Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Gennova Biopharmaceuticals Ltd., Chiron Corporation.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the pertussis vaccine market in 2023. The regions covered in pertussis vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Pertussis Vaccine Market Report Structure
3. Pertussis Vaccine Market Trends And Strategies
4. Pertussis Vaccine Market - Macro Economic Scenario
5. Pertussis Vaccine Market Size And Growth
…..
27. Pertussis Vaccine Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

"Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide."

This release was published on openPR.